Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medicus Pharma Ltd (MDCX:NASDAQ), powered by AI.
Medicus Pharma Ltd is currently trading at $0.33. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medicus Pharma Ltd on Alpha Lenz.
Medicus Pharma Ltd's P/E ratio is -0.2.
“Medicus Pharma Ltd trades at a P/E of -0.2 (undervalued) with modest ROE of -2311.2%.”
Ask for details →Medicus Pharma Ltd is a prominent pharmaceutical company engaged in the research, development, and commercialization of innovative healthcare solutions. The company's primary function is to address unmet medical needs by developing a portfolio of therapies across various therapeutic areas, including oncology, neurology, and immunology. Medicus Pharma Ltd places significant emphasis on biotechnology and cutting-edge medical research, which positions it as a key player in the life sciences sector. With a commitment to delivering high-quality and effective treatments, the company plays a vital role in advancing healthcare standards globally. Medicus Pharma Ltd not only impacts the pharmaceutical industry but also contributes to the overall well-being of patients and healthcare systems. As a market leader, it collaborates with academic institutions and other industry players to foster innovation and expedite the development of life-saving medications.
“Medicus Pharma Ltd trades at a P/E of -0.2 (undervalued) with modest ROE of -2311.2%.”
Ask for details →Medicus Pharma Ltd (ticker: MDCX) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - General). Market cap is $6M.
The current price is $0.335 with a P/E ratio of -0.16x and P/B of -85.68x.
ROE is -2311.22%.